» Articles » PMID: 31963897

The Plant-Derived Compound Resveratrol in Brain Cancer: A Review

Overview
Journal Biomolecules
Publisher MDPI
Date 2020 Jan 23
PMID 31963897
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Despite intensive research, malignant brain tumors are among the most difficult to treat due to high resistance to conventional therapeutic approaches. High-grade malignant gliomas, including glioblastoma and anaplastic astrocytoma, are among the most devastating and rapidly growing cancers. Despite the ability of standard treatment agents to achieve therapeutic concentrations in the brain, malignant gliomas are often resistant to alkylating agents. Resveratrol is a plant polyphenol occurring in nuts, berries, grapes, and red wine. Resveratrol crosses the blood‒brain barrier and may influence the central nervous system. Moreover, it influences the enzyme isocitrate dehydrogenase and, more importantly, the resistance to standard treatment via various mechanisms, such as O6-methylguanine methyltransferase. This review summarizes the anticancer effects of resveratrol in various types of brain cancer. Several in vitro and in vivo studies have presented promising results; however, further clinical research is necessary to prove the therapeutic efficacy of resveratrol in brain cancer treatment.

Citing Articles

The Potential Application of Resveratrol and Its Derivatives in Central Nervous System Tumors.

Nowacka A, Sniegocka M, Smuczynski W, Liss S, Ziolkowska E, Bozilow D Int J Mol Sci. 2025; 25(24.

PMID: 39769099 PMC: 11728356. DOI: 10.3390/ijms252413338.


Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management.

Dewanjee S, Bhattacharya H, Bhattacharyya C, Chakraborty P, Fleishman J, Alexiou A Cell Commun Signal. 2024; 22(1):497.

PMID: 39407193 PMC: 11476647. DOI: 10.1186/s12964-024-01878-2.


Resveratrol Inhibits Nasopharyngeal Carcinoma (NPC) by Targeting the MAPK Signaling Pathway.

Yi Y, Zhou B, Man T, Xu Z, Tang H, Li J Anticancer Agents Med Chem. 2024; 24(16):1207-1219.

PMID: 38988166 DOI: 10.2174/0118715206319761240705115109.


Polyphenols Modulate the miRNAs Expression that Involved in Glioblastoma.

Rezaie M, Nasehi M, Shimia M, Ebrahimnezhad M, Yousefi B, Majidinia M Mini Rev Med Chem. 2024; 24(21):1953-1969.

PMID: 38639278 DOI: 10.2174/0113895575304605240408105201.


Comparative Studies of Resveratrol, Oxyresveratrol and Dihydrooxyresveratrol on Doxorubicin-Treated Lung Cancer Cells.

Yahayo W, Pongkittiphan V, Supabphol R, Saiyudthong S Asian Pac J Cancer Prev. 2024; 25(3):939-949.

PMID: 38546076 PMC: 11152376. DOI: 10.31557/APJCP.2024.25.3.939.


References
1.
Laaniste L, Srivastava P, Stylianou J, Syed N, Cases-Cunillera S, Shkura K . Integrated systems-genetic analyses reveal a network target for delaying glioma progression. Ann Clin Transl Neurol. 2019; 6(9):1616-1638. PMC: 6764637. DOI: 10.1002/acn3.50850. View

2.
Ginkel P, Sareen D, Subramanian L, Walker Q, Darjatmoko S, Lindstrom M . Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res. 2007; 13(17):5162-9. DOI: 10.1158/1078-0432.CCR-07-0347. View

3.
Andrade S, Ramalho M, Pereira M, Loureiro J . Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment. Front Pharmacol. 2018; 9:1261. PMC: 6262174. DOI: 10.3389/fphar.2018.01261. View

4.
Nonomura S, Kanagawa H, Makimoto A . [CHEMICAL CONSTITUENTS OF POLYGONACEOUS PLANTS. I. STUDIES ON THE COMPONENTS OF KO-J O-KON. (POLYGONUM CUSPIDATUM SIEB. ET ZUCC.)]. Yakugaku Zasshi. 1963; 83:988-90. View

5.
Shah F, Gim S, Kim M, Koh P . Proteomic identification of proteins differentially expressed in response to resveratrol treatment in middle cerebral artery occlusion stroke model. J Vet Med Sci. 2014; 76(10):1367-74. PMC: 4221170. DOI: 10.1292/jvms.14-0169. View